16Indexed trials
mesh condition
Panic Disorder
Intelligence
Panic Disorder intelligence: 16 indexed trials, 5 recruiting studies, 15 sponsors across 7 countries.
5Recruiting
15Sponsors
7Countries
Leading sponsors
Massachusetts General Hospital21 recruiting
Elazığ Mental Health and Diseases Hospital10 recruiting
Johns Hopkins University10 recruiting
Karolinska Institutet10 recruiting
McMaster University10 recruiting
Neurobiologix11 recruiting
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.10 recruiting
The University of Hong Kong11 recruiting
Universidade Federal do Rio de Janeiro10 recruiting
University of Chile11 recruiting
University of Ghana11 recruiting
University of Pittsburgh10 recruiting
Geographic activity
United States6trials
Sweden2trials
Chile1trials
Brazil1trials
Turkey (Türkiye)1trials
Hong Kong1trials
Canada1trials
Leading interventions
Anxiety Focused Exposure1trials
CIDI-51trials
Caffeine1trials
Cognitive behavioral therapy (CBT)1trials
Collaborative Care1trials
Expectancy Focused Exposure1trials
Exposure Therapy1trials
Freespira Breathing System1trials
Group CBT1trials
IPT for Depression with Co-occurring Panic and Anxiety Symptoms (IPT-PS)1trials
Internet-based cognitive behavior therapy (CBT).1trials
Interpersonal Psychotherapy (IPT)1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.